Halozyme Therapeutics, Inc. (HALO)
NASDAQ·Healthcare·Biotechnology
$63.70
-1.23%
Mkt Cap $8.10B
Analyst Ratings
Buy
4
Hold
2
Sell
0
Price Target (19 analysts)
$73.83
Range $56.00 – $94.00
Implied Upside
+15.9%
Consensus $73.83 vs current $63.70
NASDAQ·Healthcare·Biotechnology
$63.70
-1.23%
Mkt Cap $8.10B
Buy
4
Hold
2
Sell
0
Price Target (19 analysts)
$73.83
Range $56.00 – $94.00
+15.9%
Consensus $73.83 vs current $63.70